Ensysce Biosciences, Inc. ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and ...
The board of directors today declared a quarterly dividend of $0.2775 per share on the company's common shares, payable November 1, 2024. Key Takeaways: The board of directors declared a quarterly ...
SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Bluebird Bio Inc. (BLUE) on Friday reported a loss of $81.4 million in its second quarter. The Somerville, Massachusetts-based company said it had a ...
SOMERVILLE, Mass., September 27, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the filing of its Form 10-Q for the quarter ended June 30, 2024 (the "Q2 2024 Form 10-Q") ...
On Thursday, bluebird bio Inc (BLUE) stock saw a modest uptick, ending the day at $0.5 which represents a slight increase of $0.02 or 4.17% from the prior close of $0.48. The stock opened at $0.51 and ...
In a report released on September 24, Mani Foroohar from Leerink Partners maintained a Hold rating on Bluebird Bio (BLUE – Research Report), with a price target of $1.00. Mani Foroohar’s rating is ...